Rain Oncology Inc. Earnings Per Share, Basic and Diluted
Rain Oncology Inc. reported Earnings Per Share, Basic and Diluted of -$0.66 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-04
- Rain Oncology Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.66.
- Rain Oncology Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.68.
- Rain Oncology Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.70.
- Rain Oncology Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.39.
- Rain Oncology Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.65.
- Rain Oncology Inc. earnings per share, basic and diluted for fiscal 2020 was -$6.29.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.66 10-Q · filed 2022-05-04 | -$1.33 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.03 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.47 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.81 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$2.65 10-K · filed 2022-03-03 |
| 2021-09-30 | -$0.70 10-Q · filed 2021-11-10 | -$1.13 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.96 10-Q · filed 2021-11-10 | -$2.86 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$0.39 10-Q · filed 2021-08-10 | -$1.23 10-Q · filed 2021-08-10 | -$2.20 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$3.95 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-03-31 | -$1.93 10-Q · filed 2022-05-04 | -$3.49 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$6.52 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$7.34 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2020-12-31 | -$1.56 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$4.60 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$5.41 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$6.29 10-K · filed 2022-03-03 |
| 2020-09-30 | -$3.05 10-Q · filed 2021-11-10 | -$3.85 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$4.73 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$0.78 10-Q · filed 2021-08-10 | -$1.60 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$0.82 10-Q · filed 2021-05-25 |